Latest News about GSK
Recent news which mentions GSK
Johnson & Johnson Offloads Rights For Hepatitis B Candidate To GSK
October 31, 2023
From Benzinga
Hope for Endometrial Cancer - GSK Drug Proves Effective in Increasing Survival Rates
October 30, 2023
Tickers
GSK
From Benzinga
GSK's Competitive Edge, Surpasses Pfizer in Respiratory Syncytial Virus Vaccine Sales
October 30, 2023
From Benzinga
Apple, AMD, Palantir Earnings On Deck This Week As Market Seeks Positive Catalysts In Fed Decision Week
October 30, 2023
From Benzinga
3 Bill Gates Stocks to Buy for Billionaire-Like Returns
October 27, 2023
From InvestorPlace
3 Deeply Undervalued Growth Stocks
October 27, 2023
From InvestorPlace
Bank Of America, Mastercard, NRA And Others Are Lobbying For Cannabis Banking Reform — Who Knew?
October 22, 2023
From Benzinga
Pfizer gets FDA green light for new shot that can streamline teenagers’ vaccinations
October 20, 2023
From MarketWatch
Startup Cerebras stands out in the high-risk AI chip arena: ‘No one has built a chip this big’
October 11, 2023
From MarketWatch
From Benzinga
China-Based Zhifei Biological Partners With GSK To Expand Shingrix Vaccine Access Across China Via £2.5B Deal
October 09, 2023
Tickers
GSK
From Benzinga
From Benzinga
From Benzinga
From Benzinga
From Benzinga
7 ‘Smart Money’ Stocks Set to Explode Higher
September 30, 2023
From InvestorPlace
Moderna's Shares Could Take Off if These 2 Things Happen
September 30, 2023
From Motley Fool
Biden's Urgent Action Against Antibiotic-Resistant Bacteria - Allocates $100M to Battle Deadly Superbugs
September 27, 2023
From Benzinga
Multi-Billion Dollar Treatment Market For Lung Infection That Causes Over 200,000 Hospitalizations Annually With Elderly, Young At Most Risk Has Game-Changing New Entrant
September 26, 2023
From Benzinga
Why Are Antifungal Focused Scynexis Stock Plunging Today?
September 25, 2023
From Benzinga
CDC Backs Pfizer's RSV Infection Maternal Vaccine During Pregnancy As Protection For Infants
September 25, 2023
From Benzinga
From Benzinga
European Commission Approves GSK/Pfizer-Backed HIV Infection Prevention Drug
September 19, 2023
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.